 j j agrees deal pharmaceutical giant agreed buy medical technology firm key producer equipment combats heart problems implant pacemakers analysts deal aimed offsetting reliance slowing drug business pointed mergers likely drug industries fragmented pressure cut costs number products facing patent expirations company battling fierce competition generic products demand heart small electric shock irregular heartbeat rhythm detected expected increase analysts widely expected firm pay closing price analysts antitrust regulators force firms shed overlapping operations tubes used artery open unblocked